These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Value of Lv Z; Fan J; Xu J; Wu F; Huang Q; Guo M; Liao T; Liu S; Lan X; Liao S; Geng W; Jin Y Eur J Nucl Med Mol Imaging; 2018 May; 45(5):735-750. PubMed ID: 29164298 [TBL] [Abstract][Full Text] [Related]
5. Predictive value of multiple metabolic and heterogeneity parameters of Shi A; Wang J; Wang Y; Guo G; Fan C; Liu J Ann Nucl Med; 2022 Apr; 36(4):393-400. PubMed ID: 35084711 [TBL] [Abstract][Full Text] [Related]
6. Identification of EGFR mutation status in male patients with non-small-cell lung cancer: role of Jiang M; Chen P; Guo X; Zhang X; Gao Q; Zhang J; Zhao G; Zheng J EJNMMI Res; 2023 Apr; 13(1):27. PubMed ID: 37014455 [TBL] [Abstract][Full Text] [Related]
7. EGFR mutation decreases FDG uptake in non‑small cell lung cancer via the NOX4/ROS/GLUT1 axis. Chen L; Zhou Y; Tang X; Yang C; Tian Y; Xie R; Chen T; Yang J; Jing M; Chen F; Wang C; Sun H; Huang Y Int J Oncol; 2019 Jan; 54(1):370-380. PubMed ID: 30431083 [TBL] [Abstract][Full Text] [Related]
8. [Evaluate the value of (18)F-FDG PET-CT imaging in predicting the mutationsin epidermal growth factor receptor in lung adenocarcinoma]. Ding CY; Yang WP; Guo Z; Sun J; Li YY; Li TR Zhonghua Zhong Liu Za Zhi; 2017 Jul; 39(7):528-531. PubMed ID: 28728300 [No Abstract] [Full Text] [Related]
9. Correlation between EGFR gene mutation, cytologic tumor markers, 18F-FDG uptake in non-small cell lung cancer. Cho A; Hur J; Moon YW; Hong SR; Suh YJ; Kim YJ; Im DJ; Hong YJ; Lee HJ; Kim YJ; Shim HS; Lee JS; Kim JH; Choi BW BMC Cancer; 2016 Mar; 16():224. PubMed ID: 26979333 [TBL] [Abstract][Full Text] [Related]
10. Biological Significance of Wang Y; Han R; Wang Q; Zheng J; Lin C; Lu C; Li L; Chen H; Jin R; He Y Int J Gen Med; 2021; 14():347-356. PubMed ID: 33568935 [TBL] [Abstract][Full Text] [Related]
11. Role of [¹⁸F]FDG PET in prediction of KRAS and EGFR mutation status in patients with advanced non-small-cell lung cancer. Caicedo C; Garcia-Velloso MJ; Lozano MD; Labiano T; Vigil Diaz C; Lopez-Picazo JM; Gurpide A; Zulueta JJ; Richter Echevarria JA; Perez Gracia JL Eur J Nucl Med Mol Imaging; 2014 Nov; 41(11):2058-65. PubMed ID: 24990403 [TBL] [Abstract][Full Text] [Related]
12. [Value of (18)F-FDG PET-CT imaging to predict epidermal growth factor receptor mutations in patients with lung squamous cell carcinoma]. Zhao CY; Deng XY; Wang HS; Cao GP; Ding JN; Ding CY Zhonghua Zhong Liu Za Zhi; 2021 Jul; 43(7):795-800. PubMed ID: 34289575 [No Abstract] [Full Text] [Related]
13. Prediction of tumor response after neoadjuvant chemoradiotherapy in rectal cancer using (18)fluorine-2-deoxy-D-glucose positron emission tomography-computed tomography and serum carcinoembryonic antigen: a prospective study. Li QW; Zheng RL; Ling YH; Wang QX; Xiao WW; Zeng ZF; Fan W; Li LR; Gao YH Abdom Radiol (NY); 2016 Aug; 41(8):1448-55. PubMed ID: 27116012 [TBL] [Abstract][Full Text] [Related]
14. Carcinoembryonic antigen in pleural effusion of patients with lung adenocarcinoma: a predictive marker for EGFR mutation. Lv YL; Liu HB; Yuan DM; Zhou L; Jin SX; Song Y Transl Cancer Res; 2019 Aug; 8(4):1027-1034. PubMed ID: 35116846 [TBL] [Abstract][Full Text] [Related]
15. Standardized uptake value on (18)F-FDG-PET/CT is a predictor of EGFR T790M mutation status in patients with acquired resistance to EGFR-TKIs. Yoshida T; Tanaka H; Kuroda H; Shimizu J; Horio Y; Sakao Y; Inaba Y; Iwata H; Hida T; Yatabe Y Lung Cancer; 2016 Oct; 100():14-19. PubMed ID: 27597275 [TBL] [Abstract][Full Text] [Related]
16. Correlation between combining Ruan M; Liu L; Wang L; Lei B; Sun X; Chang C; Shen Y; Xie W Eur J Nucl Med Mol Imaging; 2020 May; 47(5):1183-1197. PubMed ID: 31897590 [TBL] [Abstract][Full Text] [Related]
17. Performance of Zhang M; Bao Y; Rui W; Shangguan C; Liu J; Xu J; Lin X; Zhang M; Huang X; Zhou Y; Qu Q; Meng H; Qian D; Li B Front Oncol; 2020; 10():568857. PubMed ID: 33134170 [TBL] [Abstract][Full Text] [Related]
18. Correlation between EGFR mutation status and F Zhu L; Yin G; Chen W; Li X; Yu X; Zhu X; Jiang W; Jia C; Chen P; Zhang Y; Lu D; Yu L; Li X; Xu W Thorac Cancer; 2019 Apr; 10(4):659-664. PubMed ID: 30776196 [TBL] [Abstract][Full Text] [Related]
19. Comparison of clinical and radiological characteristics between anaplastic lymphoma kinase rearrangement and epidermal growth factor receptor mutation in treatment naïve advanced lung adenocarcinoma. Miao Y; Zhu S; Li H; Zou J; Zhu Q; Lv T; Song Y J Thorac Dis; 2017 Oct; 9(10):3927-3937. PubMed ID: 29268403 [TBL] [Abstract][Full Text] [Related]